Skip to content
Skip to navigation menu
24 January 2011
Three international figures from the world of medical business have given Cardiff researchers the benefit of their experience.
Professor Sir Chris Evans, Professor Chris Wood and Dr Timothy McCarthy were the lead speakers at a University seminar entitled Making Money and Discovering New Medicines.
The event was designed to give all University staff, particularly those in the early stages of their research careers, an idea of what is involved in setting up a knowledge-based business.
Professor Sir Chris Evans gave an insight into the approach which has seen him and his Excalibur team build more than 40 life sciences companies from scratch. The audience also heard of Professor Wood’s experience of more than 20 years in biotechnology, including the founding of such leading names in the sector as Nucana Biomed, Alida Capital International and Bioenvision Inc. Dr McCarthy, head of Clinical Imaging at Pfizer, gave a perspective from his background of using imaging in drug discovery and development.
The three speakers also saw poster presentations from the newly recruited President’s Scholarships students in drug discovery, a collaborative venture between five Schools, headed up by the School of Pharmacy.
Professor Chris McGuigan, School of Pharmacy, who organised the event with support from the Engineering and Physical Sciences Research Council, said: "The three speakers have a wealth of experience of turning medical research ideas into successful business. They attracted a capacity audience of enthusiastic researchers – and with luck we will see more successful business ideas coming out of Cardiff as a result!"
Cardiff hosts international rugby stars
Secrets of old age revealed
Universities’ Collaboration Celebrated
Pictures speak a thousand words
New flagship imaging centre
Pioneering surgeon leads ‘quiet revolution’ for better services
Outstanding Achievement Award
Welsh experts unite in new bid to tackle cancer
Encounters with Energy
This is an externally hosted beta service offered by Google.